clinical trial · NCT06743243
Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia
Seok Kyeong Oh·phase4·enrolling by invitation·n = 174
General AnesthesiaTegoprazanFamotidinePlacebo
brief summary
The aim of this study is to compare gastric pH right after endotracheal intubation for general anesthesia in patients pretreated with tegoprazan, famotidine, or placebo.
started
Jul 23, 2025
primary completion
Oct 30, 2026
completion
Dec 30, 2026
last updated
Sep 5, 2025
detailed description
This clinical trial is a prospective, randomized, double-blind, multicenter, investigator-initiated trial that aims to demonstrate the preventive effect of tegoprazan on preoperative aspiration in patients scheduled to undergo surgery using general anesthesia.
Subjects who meet the inclusion/exclusion criteria will be randomly assigned to the tegoprazan administration group (Group T), famotidine administration group (Group F), or placebo administration group (Group C) in the same ratio of 1:1:1.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol